51 related articles for article (PubMed ID: 34372567)
1. Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
Deng L; Liang P; Cui H
Genes Dis; 2023 Sep; 10(5):1937-1955. PubMed ID: 37492721
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections.
Najafi S; Tan SC; Aghamiri S; Raee P; Ebrahimi Z; Jahromi ZK; Rahmati Y; Sadri Nahand J; Piroozmand A; Jajarmi V; Mirzaei H
Biomed Pharmacother; 2022 Apr; 148():112743. PubMed ID: 35228065
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
Morris KV; Rossi JJ
Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Regulatory Subunit R2Alpha of Protein Kinase A in Human Glioblastoma through shRNA-Expressing Lentiviral Vectors.
Zorzan M; Del Vecchio C; Vogiatzis S; Saccon E; Parolin C; Palù G; Calistri A; Mucignat-Caretta C
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372567
[TBL] [Abstract][Full Text] [Related]
5. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
Fish RJ; Kruithof EK
BMC Mol Biol; 2004 Aug; 5():9. PubMed ID: 15291968
[TBL] [Abstract][Full Text] [Related]
6. Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skin.
Bak RO; Stenderup K; Rosada C; Petersen LB; Moldt B; Dagnæs-Hansen F; Jakobsen M; Kamp S; Jensen TG; Dam TN; Mikkelsen JG
BMC Dermatol; 2011 Feb; 11():5. PubMed ID: 21352568
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral Transduction of Primary Human Glioblastoma Cultures.
Frenster JD; Inocencio J; Placantonakis DG
Methods Mol Biol; 2018; 1741():81-89. PubMed ID: 29392692
[TBL] [Abstract][Full Text] [Related]
8. RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3.
Nóbrega C; Codêsso JM; Mendonça L; Pereira de Almeida L
Hum Gene Ther; 2019 Jul; 30(7):841-854. PubMed ID: 30760052
[TBL] [Abstract][Full Text] [Related]
9. Selective Targeting of CD133-Expressing Glioblastoma Stem Cells Using Lentiviral Vectors.
Bayin NS; Placantonakis DG
Methods Mol Biol; 2018; 1741():91-101. PubMed ID: 29392693
[TBL] [Abstract][Full Text] [Related]
10. Visualizing and interpreting cancer genomics data via the Xena platform.
Goldman MJ; Craft B; Hastie M; Repečka K; McDade F; Kamath A; Banerjee A; Luo Y; Rogers D; Brooks AN; Zhu J; Haussler D
Nat Biotechnol; 2020 Jun; 38(6):675-678. PubMed ID: 32444850
[No Abstract] [Full Text] [Related]
11. Protein Kinase A Distribution Differentiates Human Glioblastoma from Brain Tissue.
Mucignat-Caretta C; Denaro L; D'Avella D; Caretta A
Cancers (Basel); 2017 Dec; 10(1):. PubMed ID: 29267253
[TBL] [Abstract][Full Text] [Related]
12. GBM radiosensitizers: dead in the water…or just the beginning?
Bindra RS; Chalmers AJ; Evans S; Dewhirst M
J Neurooncol; 2017 Sep; 134(3):513-521. PubMed ID: 28762004
[TBL] [Abstract][Full Text] [Related]
13. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma.
Annovazzi L; Mellai M; Schiffer D
Cancers (Basel); 2017 May; 9(6):. PubMed ID: 28587121
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
